🇺🇸 FDA
Patent

US 7456190

Compositions useful as protein kinase inhibitors

granted A61PA61P11/06A61P15/00

Quick answer

US patent 7456190 (Compositions useful as protein kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P11/06, A61P15/00, A61P19/02, A61P19/10